Novozymes dominates the market with a 50 to 60 per cent share, and Genencor in second place, with about 30 per cent. The Genencor takeover move surprised observers, who had predicted the opposite; that Danisco might shuffle off its Genencor stake to fuel growth and acquisitions in the food ingredients sector. Investment in ingredients is deemed essential for the ingredients group to counterbalance lost income from the sugar unit when European sugar quota reform arrives in 2006. Investment bank Goldman Sachs predicts sugar profits for Danisco could drop by as much as 40 per cent.